| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Mrz―04 |
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study |
Melissa Davoust, Angela R. Bazzi, Samantha Blakemore, Juliana Blodgett, Anna Cheng, Sarah Fielman, Kara M. Magane, Jacqueline Theisen, Richard Saitz, Alicia S. Ventura, Zoe M. Weinstein |
| 2 |
[GO] |
2023―Okt―17 |
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff |
Shannon Gwin Mitchell, Julia Jester, Jan Gryczynski, Melanie Whitter, Douglas Fuller, Caroline Halsted, Robert P. Schwartz |
| 3 |
[GO] |
2023―Sep―13 |
Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial |
Tim Janssen, Bryan R. Garner, Julia Yermash, Kimberly R. Yap, Sara J. Becker |
| 4 |
[GO] |
2023―Mrz―29 |
“Sign Me Up”: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic |
James B. Darnton, Elenore P. Bhatraju, Kristin Beima-Sofie, Alyssa Michaels, Kevin A. Hallgren, Sean Soth, Paul Grekin, Steve Woolworth, Judith I. Tsui |
| 5 |
[GO] |
2023―Jan―20 |
Impact of the COVID-19 pandemic on burnout and perceived workplace quality among addiction treatment providers |
Andrea Fentem, Raven Riordan, Christine Doroshenko, Xiao Li, Erin Kasson, Devin Banks, Rachel P. Winograd, Patricia Cavazos-Rehg |
| 6 |
[GO] |
2022―Dez―15 |
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy |
Soroush Moallef, Kora DeBeck, Nadia Fairbairn, Zishan Cui, Rupinder Brar, Dean Wilson, Cheyenne Johnson, M.-J. Milloy, Kanna Hayashi |
| 7 |
[GO] |
2022―Nov―30 |
Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis |
Amir Hossein Behnoush, Elham Bazmi, Mehdi Forouzesh, Behnam Behnoush |
| 8 |
[GO] |
2022―Sep―05 |
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County |
Angela R. Bazzi, Alicia Harvey-Vera, Tara Buesig-Stamos, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, Thomas L. Patterson, Steffanie A. Strathdee |
| 9 |
[GO] |
2022―Apr―25 |
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis |
Suzan M. Walters, Rebecca S. Bolinski, Ellen Almirol, Stacy Grundy, Scott Fletcher, John Schneider, Samuel R. Friedman, Lawrence J. Ouellet, Danielle C. Ompad, Wiley Jenkins, Mai T. Pho |
| 10 |
[GO] |
2022―Mrz―07 |
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown |
Jacqueline Hodges, Marika Waselewski, William Harrington, Taylor Franklin, Kelly Schorling, Jacqueline Huynh, Alexa Tabackman, Kori Otero, Karen Ingersoll, Nassima Ait-Daoud Tiouririne, Tabor Flickinger, Rebecca Dillingham |
| 11 |
[GO] |
2022―Jan―29 |
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study |
Anna Cheng, Ryan Badolato, Andrew Segoshi, Ryan McDonald, Mia Malone, Kumar Vasudevan, Beita Badiei, Allison Sugarman, Ross Macdonald, Jasdeep Mangat, Jonathan Giftos, Joshua D. Lee, Babak Tofighi |
| 12 |
[GO] |
2021―Dez―11 |
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis |
Ximena A. Levander, Kim A. Hoffman, John W. McIlveen, Dennis McCarty, Javier Ponce Terashima, P. Todd Korthuis |
| 13 |
[GO] |
2021―Nov―13 |
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review |
Noa Krawczyk, Adetayo Fawole, Jenny Yang, Babak Tofighi |
| 14 |
[GO] |
2021―Jul―30 |
Protecting patients and staff in residential treatment centers during exposure to COVID-19: commentary |
Kimberly A. Johnson, Carolyn Keough, Holly Hills, Wouter Vermeer, Rebecca Lengnick-Hall, Moira McNulty, Mark McGovern, Hendricks Brown |
| 15 |
[GO] |
2021―Apr―28 |
Correction to: Adapting inpatient addiction medicine consult services during the COVID-19 pandemic |
Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, Melissa B. Weimer, Zoe M. Weinstein |
| 16 |
[GO] |
2021―Feb―24 |
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic |
Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, Melissa B. Weimer, Zoe M. Weinstein |
| 17 |
[GO] |
2021―Jan―20 |
Multiple clinical risks for cannabis users during the COVID-19 pandemic |
Ellen Mello Borgonhi, Vanessa Loss Volpatto, Felipe Ornell, Francisco Diego Rabelo-da-Ponte, Felix Henrique Paim Kessler |
| 18 |
[GO] |
2021―Jan―07 |
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model |
Ethan Cowan, Maria R. Khan, Siri Shastry, E. Jennifer Edelman |
|
